Abstract: The present application is directed at microorganisms of the genus Pseudomonas as deposited under DSM26199 (Pseudomonas sp. IPB-B26) and DSM26200 (Pseudomonas sp, N-128) with the Leibnitz Institute DSMZ. The present application is further directed at a process for the production of medium- and long-chain-length PHAs, comprising cultivating said microorganisms in a culture medium comprising a carbon source and isolating the PHA from the microorganisms. It has been observed that these microorganisms allow for efficient PHA production in high yields. In addition, the inventive microorganisms possess the valuable capability to incorporate unsaturated fatty acids into the resulting PHAs. The inventive microorganisms thus enable a later modification of the PHAs as well as cross-linking, thus opening new fields of applications for these materials.

Abstract: The present application is directed at a microorganism of the genus Pseudomonas as deposited under DSM26198 with the Leibnitz Institute DSMZ. The present application is further directed at a process for the production of medium- and long-chain PHAs, comprising cultivating said microorganism in a culture medium comprising a carbon source and isolating the PHA from the microorganism. It has been observed that the microorganism allows for PHA production in high yield. In addition, the inventive microorganism possesses the valuable capability to efficiently incorporate unsaturated and/or aromatically modified fatty acids into the resulting PHAs. Accordingly, the inventive microorganism enables the production of chemically diverse PHAs, opening new fields of applications for these materials.

Abstract: The invention concerns a hybrid plasmid for the expression of unfused 38 kDa antigen of M. tuberculosis in E. coli, E. coli with the plasmid, an 38 kDa antigen and a protein of about 33 kDa useful for diagnoses.